Anebulo Pharmaceuticals, Inc.
ANEB
Revenue
0.00
0.000.00%
-Assets
4.07M
▼-1.92M▼-32.07%
3 Months ChangeLiabilities
260.58k
▼-749.74k▼-74.21%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001493152-24-041362
2024-09-25
Form 8-K
ID: 0001493152-24-038112
2024-07-22
Form 8-K
ID: 0001493152-24-028629
2024-06-17
Form 8-K
ID: 0001493152-24-024096
2024-05-15
Form 10-Q
ID: 0001493152-24-019922
2024-05-15
Form 8-K
ID: 0001493152-24-019877
2024-02-13
Form 10-Q
ID: 0001493152-24-006103
2024-02-13
Form 8-K
ID: 0001493152-24-006087
2023-11-21
Form 8-K
ID: 0001493152-23-042292
2023-11-14
Form 10-Q
ID: 0001493152-23-041171